James Rozakis
About James Rozakis
James N. Rozakis, 47, is Executive Vice President and Chief Operating Officer of Cintas. He joined Cintas in 1999, served as Senior Vice President, Rental Division from 2016–2020, led the Rental Division as President & COO from 2020–2023, and was appointed Company EVP & COO in June 2023; he is responsible for all business divisions, enterprise sales, process improvements, apparel innovation and strategy, and marketing . In fiscal 2025, Cintas delivered record revenue of $10.34B (+8% organic) and diluted EPS of $4.40 (+16.1% YoY), with all-time highs in gross and operating margins; incentive metrics tied to EPS and sales growth for Rozakis paid between Target and Maximum based on $4.40 EPS and 7.7% sales growth . Education is not disclosed in the proxy biography .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Cintas | Senior Vice President, Rental Division | 2016–2020 | Rental Division leadership; scaled rental operations and growth |
| Cintas | President & Chief Operating Officer, Rental Division | 2020–2023 | Led Rental Division; operational and commercial execution |
| Cintas | Executive Vice President & Chief Operating Officer | 2023–Present | Oversees all business divisions; enterprise sales; process improvements; apparel innovation/strategy; marketing |
External Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Not disclosed in proxy biography | — | — | No external directorships or roles disclosed |
Fixed Compensation
| Component | FY2025 | Notes |
|---|---|---|
| Base Salary ($) | $675,338 | +3.5% vs prior year approved by Compensation Committee |
| All Other Compensation ($) | $34,100 | Includes automobile allowance, executive medical, Partners’ Plan contributions; perquisites kept minimal |
Performance Compensation
Annual Cash Incentive – FY2025 Structure and Outcomes
| Metric | Weight | Threshold | Target | Maximum | Actual FY2025 | Payout ($) |
|---|---|---|---|---|---|---|
| Diluted EPS | 42.5% | $3.91 (25%) | $4.12 (100%) | $4.41 (200%) | $4.40 (between Target and Max) | $1,210,152 (EPS+Sales subtotal) |
| Sales Growth (YoY) | 42.5% | 5.6% (25%) | 7.1% (100%) | 10.1% (200%) | 7.7% (between Target and Max) | Included above (EPS+Sales subtotal) |
| Non-Financial Goals | 15.0% | Does Not Meet (0%) | Meets (100%) | — | Meets Goals | $134,220 |
| Total Annual Incentive ($) | — | — | — | — | — | $1,344,372 |
| Target Annual Incentive ($) | — | — | $894,799 | — | — | Plan design; +29.4% target vs prior year |
Notes:
- EPS and Sales Growth goals identical across participants and derived from operating plan .
- Payouts for EPS/Sales interpolate linearly between levels; non-financial capped at 100% .
Long-Term Equity Incentives – FY2025 Design and Grants
| Element | Target Award ($) | Performance Metrics | Award Form | Grant Date | Quantity | Terms |
|---|---|---|---|---|---|---|
| FY2025 LTI Target | $1,652,856 | 50% EPS / 50% Sales Growth | Mix of options and RS | — | — | Equity awarded based on FY2025 EPS/Sales achievements |
| Stock Options | — | EPS/Sales achievements | Options | 8/11/2025 | 23,326 | Exercise price $223.88; 10-year term; vest 33% per year starting 3rd anniversary (years 3–5) |
| Restricted Stock | — | EPS/Sales achievements | RS | 8/11/2025 | 6,852 | Vests 3 years from grant |
| Stock Options | — | EPS/Sales achievements | Options | 8/15/2024 | 14,660 | Exercise price $191.935; 10-year term; vest 33% per year starting 3rd anniversary (years 3–5) |
| Restricted Stock | — | EPS/Sales achievements | RS | 8/15/2024 | 4,306 | Vests 3 years from grant |
Equity Ownership & Alignment
Beneficial Ownership and Guideline Compliance
| Item | Value | Notes |
|---|---|---|
| Total Beneficial Ownership (Shares) | 277,897 | As of Sept 2, 2025 |
| Ownership (% of Shares Outstanding) | <1% | Less than 1% of 404,391,450 shares |
| Options Exercisable within 60 Days | 0 | Included in beneficial ownership footnote |
| Unvested Restricted Stock (Shares / Value) | 35,732 / $8,093,298 | As of 5/31/2025 plus 8/11/2025 grants |
| Stock Ownership Guidelines | 3x base salary for non-CEO execs | All continuing NEOs in compliance or within window |
| Hedging/Pledging | Hedging and short sales prohibited; no pledging disclosed for Rozakis | Anti-hedging for officers; pledges disclosed for certain others, none for Rozakis |
Upcoming RSU Vesting Schedule (James N. Rozakis)
| Vesting Date | RSU Shares |
|---|---|
| 7/26/2025 | 8,776 |
| 8/10/2026 | 9,348 |
| 8/12/2027 | 10,756 |
| 8/11/2028 | 6,852 |
Outstanding Option Awards (Unexercised and Unvested)
| Grant Date | Unexercised Options (Unexercisable) | Exercise Price ($) | Expiration Date |
|---|---|---|---|
| 7/28/2020 | 8,272 | 73.39 | 7/28/2030 |
| 7/27/2021 | 33,800 | 97.22 | 7/27/2031 |
| 7/26/2022 | 41,656 | 99.46 | 7/26/2032 |
| 8/10/2023 | 41,616 | 122.54 | 8/10/2033 |
| 8/10/2023 | 9,544 | 122.54 | 8/10/2033 |
| 8/12/2024 | 37,284 | 189.91 | 8/12/2034 |
| 8/11/2025 | 23,326 | 223.88 | 8/11/2035 |
Notes: Options vest 33% annually starting on the 3rd anniversary of grant; 10-year term .
FY2025 Exercises and Vesting (Supply Overhang Indicator)
| Item | Quantity | Value Realized ($) |
|---|---|---|
| Options Exercised (FY2025) | 48,312 | $5,509,757 |
| RS/Stock Awards Vested (FY2025) | 16,900 | $3,216,873 |
Employment Terms
Agreements, Policies, and Clawbacks
- No employment or severance agreements; practice of four weeks’ written notice or pay in lieu; no change-in-control policy beyond equity plan terms .
- Change-in-control equity: if assumed or replaced, full vesting upon termination without cause or for good reason within 24 months post-CoC; if not assumed, immediate vesting at change-in-control; four weeks’ base salary cash if terminated .
- Clawbacks: Dodd-Frank Rule 10D-1 compliant Recoupment Clawback Policy (3-year lookback for restatements; includes stock price/TSR adjustments) and 2011 Misconduct Clawback Policy for detrimental conduct; no indemnification or gross-ups for clawbacks .
Potential Payments to James Rozakis (as of 5/31/2025)
| Scenario | Cash Payments ($) | Value of Unvested Options ($) | Value of Unvested RS ($) | Insurance ($) | Total ($) |
|---|---|---|---|---|---|
| Involuntary Termination Without Cause | 51,948 | — | — | — | 51,948 |
| Retirement | — | — | — | — | — (not retirement eligible per footnote) |
| Death | — | 18,749,393 | 8,093,298 | 100,000 | 26,942,691 |
| Disability | — | 18,749,393 | 8,093,298 | — | 26,842,691 |
| Qualifying Termination in Connection with Change-in-Control | 51,948 | 18,749,393 | 8,093,298 | — | 26,894,639 |
Notes: Cash equals approximately four weeks of base salary as of 5/31/2025 .
Multi-Year Compensation (Summary Compensation Table)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Salary ($) | 520,000 | 652,500 | 675,338 |
| Stock Awards ($) | 442,103 | 867,228 | 826,472 |
| Option Awards ($) | 564,102 | 1,091,912 | 826,384 |
| Non-Equity Incentive ($) | 496,080 | 1,127,647 | 1,344,372 |
| All Other Compensation ($) | 36,807 | 153,867 | 34,100 |
| Total ($) | 2,059,092 | 3,893,154 | 3,706,666 |
Compensation Structure Observations
- Pay-for-performance: Annual and long-term incentives weighted to EPS and sales growth; LT equity split between options and RS aligns upside with shareholder outcomes .
- Mix shifts: Continued use of options alongside RS indicates maintenance of at-risk equity mix (options confer upside only above grant price; RS vests on time) .
- Ownership alignment: Executive ownership guideline at 3x salary; all continuing NEOs compliant; anti-hedging in place; no pledging disclosed for Rozakis .
Governance and Shareholder Feedback
- Say-on-Pay support: 2024 advisory vote ~96% approval; Compensation Committee maintained program structure given strong support .
- Benchmarking: Market adjustments to incentive targets referenced for companies with $10–$20B revenue; peer group median revenue ~$12B (names not disclosed in proxy for comp benchmarking) .
- TSR context: Company TSR rose materially over 2021–2025 per Pay vs Performance, with $100 becoming $384.67 by FY2025; EPS progression to $4.40 supports incentive outcomes .
Investment Implications
- High alignment with shareholder outcomes: Incentives are tied to EPS and sales growth; actual FY2025 metrics were between Target and Maximum, driving meaningful cash incentive and LT equity grants; equity-heavy mix and option usage strengthen alignment with performance and valuation expansion .
- Retention dynamics: No guaranteed severance multiples or employment contracts; retention relies on substantial unvested equity with multi-year vesting and double-trigger protection post change-in-control, which mitigates abrupt departure risk while constraining cash costs .
- Insider supply considerations: FY2025 option exercises (48,312 shares) and scheduled RSU vestings through 2028 indicate periodic supply; options granted in 2024 and 2025 begin vesting in 2027 and 2028, creating future potential selling pressure windows aligned with trading policies and blackout periods .
- Risk controls and red flags: Robust clawbacks (recoupment and misconduct), anti-hedging policy, and ownership guidelines reduce governance risk; no pledging disclosed for Rozakis; related-party items disclosed elsewhere in proxy are not tied to Rozakis .
Best AI for Equity Research
Performance on expert-authored financial analysis tasks
Best AI for Equity Research
Performance on expert-authored financial analysis tasks